Virginia Commonwealth University School of Medicine researchers have discovered a new role for the bioactive lipid messenger, sphingosine-1-phosphate, or S1P, that is abundant in our blood – a finding that could lead to a new generation of drugs to fight cancer and inflammatory disease.
In the Sept. 4 issue of the journal Science, a team led by Sarah Spiegel, Ph.D., professor and chair in the VCU Department of Biochemistry and Molecular Biology and co-leader of the VCU Massey Cancer Center's cancer cell biology program, reported that the cell nucleus, which contains the DNA that codes for all of our genes, also contains and produces S1P that is important for the regulation of certain genes. Researchers have known that the nucleus contains several kinds of lipids, but their functions have remained unknown until now. The team identified the mechanisms by which cancer cells produce S1P in the nucleus and uncovered its new function there to regulate gene expression.
Spiegel, who is internationally recognized for her pioneering work on new lipid mediators that regulate cell growth and cell death, and her colleagues first discovered the role of S1P in cell growth regulation nearly a decade ago.
In this study, the team demonstrated that S1P, produced by type 2 sphingosine kinase in the nucleus, regulates genes by acting like a widely used type of cancer chemotherapeutic drug known as histone deacetylase inhibitors. Histone deacetylases are a family of enzymes that regulate expression of numerous genes that code for proteins involved in cancer and many other human diseases. Although several types of histone deacetylase inhibitors are now in clinical trials, the physiological regulators of these important enzymes were not known.
"Our work shows that S1P is a physiologically important regulator of histone deacetylases," said lead author Spiegel.
"We believe that our studies will help in the development of a new class of histone deacetylase inhibitors that might be useful for treatment of cancer and inflammatory diseases," she said.
According to Spiegel, previous investigations have shown that increased levels of type 1 sphingosine kinase, one of the two enzymes that produce S1P inside cells, but not in their nucleus, correlates with poor outcome in many types of human cancers. Spiegel and her team have previously developed a specific inhibitor of this type 1 sphingosine kinase and showed that it was effective in mice against growth of human leukemia and brain cancer tumors.
This work was supported by a grant from the National Institutes of Health.
Spiegel collaborated with VCU researchers Nitai C. Hait, Ph.D., Jeremy Allegood, Ph.D., Michael Maceyka, Ph.D., Graham M. Strub, Ph.D., Kuzhuvelil B. Harikumar, Ph.D., Sandeep K. Singh, Ph.D., and Tomasz Kordula, Ph.D. Also contributing to this work were Cheng Luo, Ph.D., from the University of Pennsylvania and Chinese Academy of Sciences; Ronen Marmorstein, Ph.D., with the University of Pennsylvania; and Sheldon Milstien, Ph.D., a neuroscientist with the National Institute of Mental Health.
About VCU and the VCU Medical Center: Virginia Commonwealth University is the largest university in Virginia with national and international rankings in sponsored research. Located on two downtown campuses in Richmond, VCU enrolls 32,000 students in 205 certificate and degree programs in the arts, sciences and humanities. Sixty-five of the programs are unique in Virginia, many of them crossing the disciplines of VCU's 15 schools and one college. MCV Hospitals and the health sciences schools of Virginia Commonwealth University compose the VCU Medical Center, one of the nation's leading academic medical centers. For more, see www.vcu.edu.
Sathya Achia Abraham | EurekAlert!
Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University
How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy